Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson Patients
100%
Alpha-synuclein (α-syn)
100%
Stem Cell-derived
100%
Midbrain Dopaminergic Neurons
100%
High Content
100%
Machine Learning Classification
100%
Induced Pluripotent Stem Cells (iPSCs)
66%
Leucine-rich Repeat Kinase 2 (LRRK2)
66%
Image-based Phenotyping
66%
Targeted Treatment
33%
Parkinson's Disease
33%
Genotype
33%
In Vitro Model
33%
Isogenic
33%
Mitochondrial Dysfunction
33%
Phosphorylation
33%
Drug Target
33%
Overexpressing
33%
SNCA Gene
33%
G2019S mutation
33%
Kinase Activity
33%
Cell Phenotype
33%
Classification Basis
33%
Machine Learning
33%
Disease Modeling
33%
Chemical Compounds
33%
Exploitability
33%
Neuron Model
33%
Dendritic Complexity
33%
384-well Plate
33%
Classification Strategy
33%
Gene Triplication
33%
Automated Fluorescence Microscopy
33%
LRRK2 Kinase
33%
Compound Treatment
33%
Isogenic Control
33%
Patient-derived
33%
Elevated Levels
33%
Biochemistry, Genetics and Molecular Biology
LRRK2
100%
Stem Cell
100%
Synuclein
100%
Dopaminergic Neuron
100%
Induced Pluripotent Stem Cell
66%
Genotyping
33%
Fluorescence Microscopy
33%
Disease Modeling
33%
Kinase
33%
Phosphotransferase
33%
Mitochondrial Disorder
33%
Serine
33%
phosphorylation
33%
Neuroscience
Stem Cell
100%
Dopaminergic Neuron
100%
Synuclein
100%
Parkinson's Disease
100%
Midbrain
100%
Kinase
33%
Disease Modeling
33%
In Vitro
33%
Serine
33%
phosphorylation
33%